UBT251 Injection Phase Ⅲ Study (Overweight or Obesity)

NCT07648225 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity & Overweight

Interventions

DRUG: UBT251 Injection 4.0 mg
DRUG: UBT251 Injection 6.0 mg
DRUG: UBT251 Injection Placebo 4.0 mg
DRUG: UBT251 Injection Placebo 6.0 mg

Sponsor

The United Bio-Technology (Hengqin) Co., Ltd.